Compare CLDX & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | KN |
|---|---|---|
| Founded | N/A | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2008 | N/A |
| Metric | CLDX | KN |
|---|---|---|
| Price | $25.87 | $23.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $44.10 | $22.33 |
| AVG Volume (30 Days) | 738.8K | ★ 765.6K |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | $2,599,000.00 | ★ $573,500,000.00 |
| Revenue This Year | N/A | $9.26 |
| Revenue Next Year | $23.23 | $5.87 |
| P/E Ratio | ★ N/A | $49.03 |
| Revenue Growth | N/A | ★ 4.24 |
| 52 Week Low | $14.40 | $12.19 |
| 52 Week High | $30.50 | $24.54 |
| Indicator | CLDX | KN |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 62.23 |
| Support Level | $25.15 | $21.90 |
| Resistance Level | $28.00 | $23.60 |
| Average True Range (ATR) | 1.16 | 0.60 |
| MACD | -0.09 | 0.18 |
| Stochastic Oscillator | 28.96 | 99.56 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.